Cargando…
Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
BACKGROUND: The identification of protein biomarkers to guide treatment decisions regarding adjuvant therapies for high-risk non-muscle-invasive bladder cancer (NMIBC) has been of increasing interest. Evidence of the impact of tumor suppressor gene product p53 and cell proliferation marker Ki-67 on...
Autores principales: | Vetterlein, Malte W., Roschinski, Julia, Gild, Philipp, Marks, Phillip, Soave, Armin, Doh, Ousman, Isbarn, Hendrik, Höppner, Wolfgang, Wagner, Walter, Shariat, Shahrokh F., Brausi, Maurizio, Büscheck, Franziska, Sauter, Guido, Fisch, Margit, Rink, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760387/ https://www.ncbi.nlm.nih.gov/pubmed/29354488 http://dx.doi.org/10.21037/tau.2017.11.10 |
Ejemplares similares
-
Female with bladder cancer: what and why is there a difference?
por: Marks, Phillip, et al.
Publicado: (2016) -
Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
por: Janisch, Florian, et al.
Publicado: (2019) -
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
por: Soave, Armin, et al.
Publicado: (2020) -
Exploring the intersection of functional recurrence, patient-reported sexual function, and treatment satisfaction after anterior buccal mucosal graft urethroplasty
por: Vetterlein, Malte W., et al.
Publicado: (2021) -
Penile Flap Inversion Vaginoplasty in Transgender Women: Contemporary Morbidity and Learning-Curve Analysis From a High-Volume Reconstructive Center
por: Maurer, Valentin, et al.
Publicado: (2022)